EVARIFU:?

Hasan Iner1, Ismail Yurekli2, Erturk Karaagac1

  • 1Department of Cardiovascular Surgery, Ataturk Training and Research Hospital, Izmir Katip Celebi University, 35360 Karabaglar, Izmir, Türkiye.

PubMed
概括

在制造商使用说明书 (IFU) 外的内血管动脉瘤修复 (EVAR) 增加了内脏泄漏和重新干预等风险,尽管5年生存率仍然相似. 对于非IFU EVAR决策而言,患者特定评估至关重要.